BioSpace News Archive

Health Canada authorized Medicago’s Covifenz COVID-19 vaccine for the prevention of COVID-19 in adults 18 to 64 years of age.

Phosphorus, a leading preventative genomics company, announced that it had entered into a partnership with Mikrogen, a genetic diagnosis laboratory focused on reproductive genetics, to offer GeneCompass, the Phosphorus holistic, medical-grade genetic test, to Mikrogen customers throughout the Middle East and Europe.

We are pleased to report that the first patient has been dosed in EBIQ-101, a study using electroencephalography (EEG) to observe variability in neurological activity in patients prior to, during, and after ketamine treatments

Antibody drug conjugates are the novel class of drugs which deliver the chemotherapeutic drug directly to the cancer cell.

SIWA THERAPEUTICS, INC announced that it has appointed Deborah Wince-Smith to its Board of Directors, effective February 22, 2022.

Relay Therapeutics, Inc., a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, reported fourth quarter and full year 2021 financial results and corporate highlights.

Codexis, Inc., a leading enzyme engineering company enabling the promise of synthetic biology, announced financial results for the fourth quarter and fiscal year ended December 31, 2021 and provided a business update.

Vaxart, Inc. (NASDAQ: VXRT) issued its business update today for the fourth quarter and full year 2021, reporting forward momentum for the Company, including its oral norovirus and COVID-19 vaccine candidates.

MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on developing and commercializing innovative antibody-based therapeutics for the treatment of cancer, today provided an update on its recent corporate progress and reported financial results for the year ended December 31, 2021.

Shineco, Inc. announced that the Company entered into a strategic cooperation agreement with Beijing Xihuan Psychological Consulting Co., Ltd., a Beijing-based comprehensive psychological consulting company, on February 21, 2022 to jointly build an industry-university-research-medical collaborative platform for psychological rehabilitation of tumor patients.